Latest News and Press Releases

Nanterre, le 16 mars 2026 Déclaration des transactions sur actions propres(période du 9 au 13 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5...

Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and...

WASHINGTON, April 30, 2025 (GLOBE NEWSWIRE) -- Key Highlights Pending home sales in March leapt 6.1%.Compared to one month ago, pending home sales declined in the Northeast, while the Midwest,...

SmartCentres Declares Distribution for March 2025

Record sales of € 208.9 million (2021: € 170.0 million) Operational EBITDA € 22.5 million (2021: € 29.0 million)Net Income from operations € 1.5 million (2021: € 3.4 million)Proposed distribution of €...

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...

- Company Produces a Record 1,259 BTC in Q1 2022, up 556% Year-Over-Year from Q1 2021 and up 15% Sequentially from Q4 2021- Total Bitcoin Holdings Increase to 9,374 BTC- Hash Rate Increased 14% from...

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 26, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...

Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) -- The Keg Royalties Income Fund (the “Fund”) (TSX:...

LEXINGTON, Mass. and AMSTERDAM, March 03, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...